CHICAGO -- A mutation-agnostic gene therapy for retinitis pigmentosa (RP) showed promise for improving vision in severely vision-impaired and blind patients, a randomized clinical trial showed. After ...

NEW YORK CITY -- A form of light therapy led to durable improvement in visual acuity for patients with dry age-related macular degeneration, according to interim results from an ongoing randomized ...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies ...

On Wednesday, LENZ Therapeutics Inc (NASDAQ:LENZ) released topline results from its Phase 3 CLARITY study of two investigational formulations of aceclidine, LNZ100 and LNZ101. Presbyopia is the ...

One of the best ways to improve eyesight is consuming enough vitamin A which can be found in foods like carrots, sweet potatoes, and spinach. You can also protect your eyesight from further damage by ...

Age-related macular degeneration (AMD) is a leading cause of vision loss among people aged 50 and older. While treatments for the wet form of AMD have shown promise, the dry form, which accounts for ...

Please provide your email address to receive an email when new articles are posted on . Access to low-vision services led to significant improvement in vision and quality of life for patients with ...

Nanoscope Therapeutics has agreed with the US Food and Drug Administration (FDA) on the design of its Phase III trial following a successful Phase II study of its gene therapy in Stargardt disease.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. LNZ100, an aceclidine-based eye drop, demonstrated a ...

Although the rise of modern vision enhancements has drawn growing interest, many spectacle-wearing consumers remain attached to the traditional and practical offerings of eyeglasses. As advancements ...